Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy

Journal of Biomedical Optics

Volumn 20, Issue 6, 2015, Pages

  Schweitzer, Dietrich ^a   Deutsch, Lydia ^a   Klemm, Matthias ^b   Jentsch, Susanne ^a   Hammer, Martin ^a   Peters, Sven ^a   Haueisen, Jens ^b   Müller, Ulrich A ^a   Dawczynski, Jens ^c  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b ILMENAU UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

advanced glycation end products.; diabetes; flavin adenine dinucleotide; fluorescence lifetime imaging ophthalmoscopy; metabolism; reduced nicotinamide adenine dinucleotide

Indexed keywords

AMIDES; FLUORESCENCE; GLYCOSYLATION; GRAPHIC METHODS; MEDICAL PROBLEMS; METABOLISM; NUCLEOTIDES; PIXELS;

ADVANCED GLYCATION END PRODUCTS; AGE-MATCHED CONTROLS; DIABETIC RETINOPATHY; FLAVIN ADENINE DINUCLEOTIDE; FLUORESCENCE LIFETIME IMAGING; NICOTINAMIDE ADENINE DINUCLEOTIDES; RELATIVE CONTRIBUTION; TIME RESOLVED AUTOFLUORESCENCE;

EYE PROTECTION;

ADULT; AGED; CASE CONTROL STUDY; DIABETIC RETINOPATHY; EYE FUNDUS; FEMALE; FLUORESCENCE IMAGING; HUMAN; LENS; LIGHT RELATED PHENOMENA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PATHOLOGY; PROCEDURES;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FUNDUS OCULI; HUMANS; LENS, CRYSTALLINE; MALE; MIDDLE AGED; OPHTHALMOSCOPY; OPTICAL IMAGING; OPTICAL PHENOMENA;

EID: 84924812965     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.20.6.061106     Document Type: Article

References (37)

1. Y. Ohkubo et al., "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin dependent diabetes mellitus: a randomized prospective 5-year study, " Diab. Res. Clin. Pract. 28, 103-117 (1995).
2. UK Prospektive Diabetes Study (UKPDS) Group, "Intensive blood-glucose control with sulfonyl ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), " Lancet 352, 837-853 (1998).
3. A. J. Barber, T. W. Gardner, and S. F. Abcouwer, "The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy, " Invest. Ophthalmol. Vis. Sci. 52, 1156-1162 (2011).
4. A. J. Barber et al., "Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin, " J. Clin. Invest. 102, 783-791 (1998).
5. A. B. El-Remessy et al., "Neuroprotective and blood-retinal barrierpreserving effect of cannabitol in experimental diabetes, " Am. J. Pathol. 168, 235-244 (2006).
6. R. M. H. Diederen et al., "Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy, " Invest. Ophthalmol. Vis. Sci. 47, 2726-2731 (2006).
7. M. S. Ola et al., "Analysis of glucose metabolism in diabetic rat retinas, " Am. J. Physiol. Endocrinol. Metab. 290, E1057-E1067 (2006).
8. Y. Ido et al., "Early neural and vascular dysfunction in diabetic rats are largely sequelae of increased sorbitol oxidation, " Antioxid. Redox Signal. 12, 39-51 (2010).
9. E. Lieth et al., "Retinal neurodegeneration: early pathology in diabetes, " Clin. Exp. Ophthalmol. 28, 3-8 (2000).
10. J. H. Yang et al., "Retinal neurodegeneration in type II diabetic Otsuka Long-Evans Tokusshima fatty rats, " Invest. Ophthalmol. Vis. Sci. 54, 3844-3851 (2013).
11. R. U. Kowluru and S. N. Abbas, "Diabetes-induced mitochondrial dysfunction in the retina, " Invest. Ophthalmol. Vis. Sci. 44, 5327-5334 (2003).
12. M. G. Field et al., "Rapid, noninvasive detection of diabetes-induced retinal metabolic stress, " Arch. Ophthalmol. 126(7), 934-938 (2008).
13. F. C. Delori et al., "In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics, " Invest. Ophthalmol. Vis. Sci. 36(3), 718-729 (1995).
14. D. Schweitzer, "Ophthalmic applications of FLIM, " Chapter 20 in Fluorescence Lifetime Spectroscopy and Imaging, L. Marcu, P. M. W. French, and D. S. Elson, Eds., pp. 423-447, CRC Press, Boca Raton, FL (2014).
15. Early Treatment Diabetic Retinopathy Study Research Group., "Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10, " Ophthalmology 98, 786-806 (1991).
16. H. W. van Dijk et al., "Early neurodegeneration in the retina of type 2 diabetic patients, " Invest. Ophthalmol. Vis. Sci. 53, 2715-2719 (2012).
17. D. Schweitzer et al., "Towards metabolic mapping of the human retina, " Microsc. Res. Tech. 70, 410-419 (2007).
18. D. Schweitzer, "Quantifying fundus autofluorescence, " Chapter 8 in Fundus Autofluorescence, N. Lois and J. V. Forrester, Eds., pp. 78-95, Wolters Kluwer LippincottWilliams &Wilkins, Philadelphia, PA (2009).
19. E. Y. Chew et al., "Evaluation of the age-related eye disease study clinical lens grading system AREDS report no. 31, " Ophthalmology 117, 2112-2119 (2010).
20. L. Deutsch, "Evaluierung des Fluorescence Lifetime Imaging vom Augenhintergrund bei Patienten mit Diabetes mellitus, " MD Dissertation, FSU Jena, Germany (2012).
21. C. Dysli et al., "Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects, " Invest. Ophthalmol. Vis. Sci. 55, 2106-2113 (2014).
22. C. Kloos et al., "Unnoticed shift in the normal range of glycated HbA1c with TOSOH high performance liquid chromatography, " Diabetologia 54(Suppl. 1), 401 (2011).
23. Diabetes Control and Complication Trial Research Group, "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, " N. Engl. J. Med. 329, 977-986 (1993).
24. S. Holm, "A simple sequentially rejective multiple test procedure, " Scand. J. Stat. 6, 65-70 (1979).
25. M. Klemm, private communication, University of Technology, Institute of Biomedical Engineering and Informatics, Ilmenau, Germany (2010).
26. M. Klemm et al., "Repeatability of autofluorescence lifetime imaging at the human fundus in healthy volunteers, " Curr. Eye Res. 38, 793-801 (2013).
27. D. Schweitzer et al., "Spectral and time-resolved studies on ocular structures, " Proc. SPIE 6628, 662807 (2007).
28. S. Peters, M. Hammer, and D. Schweitzer, "Two-photon excited fluorescence microscopy application for ex vivo investigation of ocular fundus samples, " Proc. SPIE 8086, 808605 (2011).
29. D. Schweitzer et al., "Time-resolved autofluorescence imaging of human donor retina tissue from donors with significant extramacular drusen, " Invest. Ophthalmol. Vis. Sci. 53, 3376-3386 (2012).
30. D. Schweitzer et al., "Detection of early metabolic alterations in the ocular fundus of diabetic patients by time-resolved autofluorescence of endogenous fluorophores, " Proc. SPIE 8087, 80871G (2011).
31. S. E. Inzucchi et al., "Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), " Diabetes Care 35, 1364-1379 (2012).
32. H. H. Abholz et al., "Nationale Versorgungs Leitlinie Therapie des Typ-2 diabetes, " Dtsch. Arztebl. 110(40), A-1875/B-1655/C-1623 (2013).
33. H. D. Vishwasrao et al., "Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotrophy, " J. Biol. Chem. 280, 25119-25126 (2005).
34. D. Schweitzer, "Metabolic mapping, " Chapter 10 in Medical Retina, F. G. Holz and R. F. Spaide, Eds., pp. 107-123, Springer, Berlin Heidelberg (2010).
35. V. Jyothikumar, Y. Sun, and A. Periasamy, "Investigation of tryptophan-NADH interactions in live human cells using three-photon fluorescence lifetime imaging and Förster resonance energy transfer microscopy, " J. Biomed. Opt. 18, 060501 (2013).
36. M. C. Skala et al., "In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia, " PNAS 104(49) 19494-19499 (2007).
37. D. Schweitzer, M. Hammer, and F. Schweitzer, "Limitations of the confocal laser scanning technique in measurements of time-resolved autofluorescence of the ocular fundus, " Biomed. Tech. (Berl.) 50, 263-267 (2005).